恒瑞医药(01276.HK)10月28日耗资7576.91万元回购118.6万股A股
Ge Long Hui·2025-10-28 09:07

Core Viewpoint - Heng Rui Medicine (01276.HK) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - The company plans to repurchase 1.186 million A-shares at a total cost of RMB 75.7691 million [1] - The buyback price per share is set between RMB 63.61 and RMB 64.01 [1]